Clinical Trial Update: Plerixafor and Filgrastim Following Cyclophosphamide for Stem Cell Mobilization in Patients With Multiple Myeloma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating stem cell mobilization with plerixafor and filgrastim after cyclophosphamide in patients with multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Filgrastim (filgrastim)
• Plerixafor (Plerixafor)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Refractory Multiple Myeloma, Stage I Multiple Myeloma | Phase 1 | Status: COMPLETED